A Phase II, Randomised, Double-Blind, Parallel-Group, Placebo-Controlled, Multi-Centre Study To Assess the Activity Of Once-Daily Orally Administered ZD4054 15MG and 10MG Doses On Bone Metastases In Pain-Free Or Mildly Systematic Patients..

Short title	A Phase II, Randomised, Double-Blind, Parallel-Group, Placebo-Controlled, Multi-Centre Study To Assess the Activity Of Once-Daily Orally Administered ZD4054 15MG and 10MG Doses On Bone Metastases In Pain-Free Or Mildly Systematic Patients..
Status	Finished
Effective start/end date	1/01/05 → 31/12/07

Project Details